Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
Ongoing health technology assessments by the SBU in Sweden
The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) independently reviews healthcare and social service interventions, assessing effectiveness, harms, cost-effectiveness, and ethical or social aspects to inform policy and clinical decisions. It identifies knowledge gaps but does not issue clinical guidelines.
As of September 2025, the SBU is working on several health technology assessments, including the following Med Tech-related topics:
- Newborn Screening for Metachromatic Leukodystrophy;
- Reliability of algorithm-based diagnostics for suspected or elevated risk of ovarian cancer;
- Measurement methods for prioritized outcomes regarding provoked vulvodynia (vestibulitis).
See the full details in Swedish here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.